Clinical Trials
33 trialsComparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery
NRG Oncology
Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease
M.D. Anderson Cancer Center
Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases
M.D. Anderson Cancer Center
PRAMECE
Centre Oscar Lambret
CLQ
Instituto Nacional de Cancerologia de Mexico
Comparison of Contrast Agents for MRI Perfusion Analysis in Brain Tumor Patients
University of Nebraska
Anti-NY ESO-1 mTCR Peripheral Blood Lymphocytes
Albert Einstein College of Medicine
Fractionated Stereotactic Radiotherapy (FSRT) in Treatment of Brain Metastases
H. Lee Moffitt Cancer Center and Research Institute
HGS-ETR2 to Treat Children With Solid Tumors
National Institutes of Health Clinical Center (CC)
HX4 SD
Maastricht Radiation Oncology
Stereotactic Radiosurgery After Surgery in Treating Patients With Brain Metastases
Duke University
CEST- Glucose Enhanced MRI for Metastatic Brain Tumours
British Columbia Cancer Agency
Pharmacokinetics of Systemic Anti-Cancer Therapies in the Cerebrospinal Fluid (CSF) of Patients With Advanced Cancer
Duke University
CaBaMet
AIO-Studien-gGmbH
NRR
UNC Lineberger Comprehensive Cancer Center
Study of Temozolomide in the Treatment of Brain Metastasis From Non-small-cell Lung Cancer (Study P02143)
Merck Sharp & Dohme LLC
Melphalan With BBBD in Treating Patients With Brain Malignancies
OHSU Knight Cancer Institute
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Alliance for Clinical Trials in Oncology
A Phase II Study of Dacomitinib in Progressive Brain Metastases
University of California, San Diego
Neurocognition After Gamma Knife Radiosurgery for Multiple Brian Metastases
CancerCare Manitoba
Sunitinib Malate After Stereotactic Radiosurgery in Treating Patients With Newly Diagnosed Brain Metastases
Case Comprehensive Cancer Center
Study of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain Metastases
Pharmacyclics LLC.
Riluzole and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
Rutgers, The State University of New Jersey
Stereotactic Radiosurgery in Treating Patients With Brain Metastases
Duke University
S9903: Whole Brain Radiotherapy Followed By Stereotactic Radiosurgery for Limited Malignant Melanoma Brain Metastases
SWOG Cancer Research Network
Capecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast Cancer
M.D. Anderson Cancer Center
Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That Is Metastatic to the Brain
European Organisation for Research and Treatment of Cancer - EORTC
Adjuvant Radiation Therapy in Treating Patients With Brain Metastases
European Organisation for Research and Treatment of Cancer - EORTC
CN-306
Tufts Medical Center
11C Topotecan PET Imaging
Case Comprehensive Cancer Center
Everolimus and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastasis From Non-Small Cell Lung Cancer
Vanderbilt-Ingram Cancer Center
TACTIC
University College, London
Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin
Case Comprehensive Cancer Center